 double-masked study cyclosporine treatment endogenous uveitis Fifty-six patients bilateral sight-threatening noninfectious intermediate posterior uveitis randomized double-masked study use cyclosporine vs prednisolone treatment end-point definitions visual acuity vitreal haze patients group macular edema patients cyclosporine-treated group ten patients prednisolone-treated group therapies cyclosporine prednisolone trials drugs additional patient improvements Secondary effects therapeutic alternatives notable alterations serum creatinine concentration hypertension dosage cyclosporine